\u4f5c\u4e3a\u4e3a\u60a3\u8005\u63d0\u4f9b\u66f4\u5b89\u5168\u8840\u6db2\u4f9b\u5e94\u7684\u6301\u7eed\u52aa\u529b\u7684\u4e00\u90e8\u5206\uff0c\u4e16\u754c\u5404\u5730\u8d8a\u6765\u8d8a\u591a\u7684\u8840\u5e93\u5f00\u59cb\u5b9e\u65bd\u620a\u578b\u809d\u708e\u75c5\u6bd2 (HEV) \u7b5b\u67e5\u7cfb\u7edf\u3002HEV \u611f\u67d3\u662f\u4e00\u79cd\u5e38\u89c1\u611f\u67d3\uff0c\u53ef\u5728\u90e8\u5206\u60a3\u8005\u4e2d\u5bfc\u81f4\u4e25\u91cd\u751a\u81f3\u5371\u53ca\u751f\u547d\u7684\u540e\u679c\u3002<\/p>\n
\u5728\u6cf0\u56fd\uff0c\u6cf0\u56fd\u7ea2\u5341\u5b57\u4f1a\u56fd\u5bb6\u8840\u6db2\u4e2d\u5fc3\u5728 2023\u20132027 \u8d22\u5e74\u671f\u95f4\uff0c\u6bcf\u6708\u5bf9\u7ea6 500 \u4e2a\u8840\u6db2\u5355\u4f4d\u5f00\u5c55 HEV \u7b5b\u67e5\u3002 \u8be5\u5021\u8bae\u65e8\u5728\u964d\u4f4e HEV \u611f\u67d3\u98ce\u9669\uff0c\u5c24\u5176\u662f\u598a\u5a20\u671f\u60a3\u8005\u3001\u514d\u75ab\u529f\u80fd\u53d7\u635f\u60a3\u8005\u4ee5\u53ca\u5176\u4ed6\u9762\u4e34 HEV \u611f\u67d3\u76f8\u5173\u4e0d\u826f\u7ed3\u5c40\u9ad8\u98ce\u9669\u7684\u60a3\u8005\u7fa4\u4f53\u3002<\/p>\n
\u5728\u672c\u62a5\u544a\u4e2d\uff0c\u6211\u4eec\u5c06\u56de\u987e HEV \u7684\u6982\u51b5\u53ca\u6d41\u884c\u75c5\u5b66\u7279\u5f81\uff0c\u4ee5\u8bf4\u660e\u4e3a\u4ec0\u4e48\u4e00\u4e9b\u8840\u5e93\u9009\u62e9\u5e94\u5bf9\u8fd9\u4e00\u95ee\u9898\uff1b\u540c\u65f6\u4ecb\u7ecd HEV \u7b5b\u67e5\u6d41\u7a0b\u7684\u5177\u4f53\u5f00\u5c55\u65b9\u5f0f\uff0c\u5305\u62ec\u5728\u5b9e\u9a8c\u5ba4\u6280\u672f\u548c\u653f\u7b56\u5c42\u9762\u7684\u76f8\u5173\u8003\u91cf\u3002\u6700\u540e\uff0c\u6211\u4eec\u5c06\u5c55\u793a\u4e00\u4e9b\u6765\u81ea\u6cf0\u56fd\u7684\u6570\u636e\uff0c\u4ee5\u8bf4\u660e\u6cf0\u56fd\u7ea2\u5341\u5b57\u4f1a\u4e3a\u4f55\u51b3\u5b9a\u5b9e\u65bd HEV \u7b5b\u67e5\u3002<\/p>\n
HEV \u662f\u4e00\u79cd\u6b63\u94fe\u3001\u5355\u80a1\u3001\u65e0\u5305\u819c\u7684 RNA \u75c5\u6bd2\uff0c\u96b6\u5c5e\u4e8e\u809d\u75c5\u6bd2\u79d1\u809d\u75c5\u6bd2\u5c5e\u8be5\u75c5\u6bd2\u81f3\u5c11\u6709\u56db\u79cd\u4e0d\u540c\u7684\u57fa\u56e0\u578b\uff1a\u57fa\u56e0 1 \u578b\u30012 \u578b\u30013 \u578b\u548c 4 \u578b\u3002\u57fa\u56e0 1 \u578b\u548c 2 \u578b\u611f\u67d3\u4eba\u7c7b\uff0c\u800c\u57fa\u56e0 3 \u578b\u548c 4 \u578b\u6d41\u884c\u4e8e\u591a\u79cd\u52a8\u7269\u5bbf\u4e3b\u4e2d\uff0c\u5305\u62ec\u732a\u3001\u91ce\u732a\u548c\u9e7f\u3002\u57fa\u56e0 3 \u578b\u548c 4 \u578b\u5076\u5c14\u4f1a\u611f\u67d3\u4eba\u7c7b [1]\u3002<\/p>\n
\u6839\u636e\u4e16\u754c\u536b\u751f\u7ec4\u7ec7 (WHO) \u7684\u6570\u636e\uff0c\u5168\u7403\u6bcf\u5e74\u65b0\u8bca\u65ad\u51fa\u7ea6 2000 \u4e07\u4f8b\u620a\u578b\u809d\u708e\u75c5\u6bd2\u611f\u67d3\uff0c\u5176\u4e2d\u7ea6\u6709 330 \u4e07\u4f8b\u4e3a\u6709\u75c7\u72b6\u611f\u67d3\u75c5\u4f8b [1]\u3002\u5357\u4e9a\u548c\u4e1c\u4e9a\u7684\u60a3\u75c5\u7387\u6700\u9ad8\u30022015 \u5e74\uff0cWHO \u4f30\u8ba1\u7ea6\u6709 44,000 \u4eba\u6b7b\u4e8e HEV \u611f\u67d3 [1]\u3002<\/p>\n
\u4ee5\u4e0b\u662f HEV \u611f\u67d3\u7684\u56db\u79cd\u4e3b\u8981\u4f20\u64ad\u9014\u5f84\uff1a(1) \u901a\u8fc7\u98df\u7528\u53d7\u6c61\u67d3\u7684\u98df\u7269\u548c\u6c34\u8fdb\u884c\u7caa\u53e3\u4f20\u64ad\uff1b(2) \u6444\u5165\u53d7\u611f\u67d3\u52a8\u7269\u7684\u672a\u716e\u719f\u8089\u7c7b\uff1b(3) \u5782\u76f4\u4f20\u64ad\uff1b\u4ee5\u53ca (4) \u8f93\u6ce8\u611f\u67d3\u7684\u8840\u6db2\u5236\u54c1\uff0c\u8fd9\u79cd\u60c5\u51b5\u79f0\u4e3a\u8f93\u8840\u4f20\u64ad\u6027 HEV \u611f\u67d3\uff08TT-HEV \u611f\u67d3\uff09[1]\u3002<\/p>\n
HEV \u611f\u67d3\u7684\u6f5c\u4f0f\u671f\u4e3a 2 \u81f3 10 \u5468\uff0c\u5e73\u5747\u4e3a 5 \u81f3 6 \u5468\u3002\u5927\u591a\u6570 HEV \u611f\u67d3\u60a3\u8005\u6ca1\u6709\u75c7\u72b6\u3002HEV \u611f\u67d3\u7684\u75c7\u72b6\u548c\u4f53\u5f81\u53ef\u5305\u62ec\u53d1\u70ed\u3001\u538c\u98df\u3001\u6076\u5fc3\u3001\u5455\u5410\u3001\u8179\u75db\u3001\u7619\u75d2\u3001\u76ae\u75b9\u3001\u5173\u8282\u75db\u3001\u9ec4\u75b8\u548c\u809d\u80bf\u5927\u3002\u8fd9\u4e9b\u75c7\u72b6\u901a\u5e38\u6301\u7eed 1 \u81f3 6 \u5468\u3002\u673a\u4f53\u9488\u5bf9 HEV \u7684\u514d\u75ab\u529b\u5c06\u5728\u6025\u6027\u611f\u67d3\u6e05\u9664\u540e\u5f62\u6210\u3002\u5728\u5927\u591a\u6570\u60a3\u8005\u4e2d\uff0c\u611f\u67d3\u5448\u81ea\u9650\u6027\u8fc7\u7a0b [1]\u3002<\/p>\n
\u7f55\u89c1\u60c5\u51b5\u4e0b\uff0c\u6025\u6027 HEV \u611f\u67d3\u53ef\u5bfc\u81f4\u66b4\u53d1\u6027\u809d\u708e\uff08\u6025\u6027\u809d\u810f\u8870\u7aed\uff09\u3002HEV \u611f\u67d3\u4ea6\u53ef\u5728\u5b55\u5987\u4e2d\u5bfc\u81f4\u8f83\u9ad8\u7684\u75c5\u6b7b\u7387\u548c\u80ce\u513f\u4e27\u5931\uff0c\u5c24\u5176\u662f\u598a\u5a20\u4e2d\u3001\u665a\u671f\u7684\u5b55\u5987\u3002\u6b64\u5916\uff0cHEV \u8fd8\u53ef\u80fd\u5bfc\u81f4\u514d\u75ab\u529f\u80fd\u53d7\u6291\u5236\u4e2a\u4f53\u53d1\u751f\u6162\u6027\u611f\u67d3\uff0c\u4f8b\u5982\u4eba\u7c7b\u514d\u75ab\u7f3a\u9677\u75c5\u6bd2 (HIV) \u611f\u67d3\u8005\u548c\u4f7f\u7528\u514d\u75ab\u6291\u5236\u836f\u7269\u7684\u5668\u5b98\u79fb\u690d\u60a3\u8005 [1]\u3002<\/p>\n
\u7531\u4e8e\u5927\u591a\u6570 HEV \u611f\u67d3\u8005\u65e0\u75c7\u72b6\u4e14\u672a\u88ab\u53d1\u73b0\uff0c\u56e0\u6b64\u4ed6\u4eec\u4ecd\u6709\u53ef\u80fd\u524d\u6765\u732e\u8840\u3002\u5148\u524d\u7814\u7a76\u663e\u793a\uff0c\u732e\u8840\u8005\u4e2d HEV \u611f\u67d3\u7684\u60a3\u75c5\u7387\u8303\u56f4\u4e3a 1:600 \u81f3 1:74,131 [2]\u3002<\/p>\n
\u90e8\u5206\u56fd\u5bb6\/\u5730\u533a\u5df2\u6839\u636e\u5404\u5730\u533a\u732e\u8840\u8005\u4e2d HEV \u7684\u6d41\u884c\u60c5\u51b5\uff0c\u5bf9\u732e\u8840\u8005\u5b9e\u65bd\u5168\u9762\u6216\u9009\u62e9\u6027\u7684 HEV \u7b5b\u67e5\u3002\u6838\u9178\u6269\u589e\u68c0\u6d4b (NAT) \u662f HEV \u611f\u67d3\u7684\u9996\u9009\u7b5b\u67e5\u65b9\u6cd5\uff0c\u56e0\u4e3a\u53d7\u611f\u67d3\u7684\u732e\u8840\u8005\u5e38\u89c1\u809d\u9176\u6c34\u5e73\u6b63\u5e38\uff0c\u5e76\u4e14\u6297 HEV IgM \u548c IgG \u68c0\u6d4b\u7ed3\u679c\u5448\u9634\u6027\u3002<\/p>\n
\u5927\u591a\u6570 TT-HEV \u611f\u67d3\u60a3\u8005\u6ca1\u6709\u75c7\u72b6\u3002\u60a3\u8005\u53ef\u80fd\u8868\u73b0\u4e3a\u809d\u529f\u80fd\u68c0\u67e5\u8f7b\u5ea6\u5f02\u5e38\uff0c\u4ece\u800c\u5bb9\u6613\u5bfc\u81f4\u6cbb\u7597\u5ef6\u8fdf\u3002\u7136\u800c\uff0c\u5c11\u6570\u60a3\u8005\u5728\u63a5\u53d7\u611f\u67d3\u7684\u8840\u6db2\u53ca\u8840\u6db2\u5236\u54c1\u540e\uff0c\u53ef\u80fd\u4f1a\u51fa\u73b0\u809d\u708e\u7684\u4f53\u5f81\u548c\u75c7\u72b6\u3002\u514d\u75ab\u6291\u5236\u7684\u60a3\u8005\u4e5f\u66f4\u5bb9\u6613\u53d1\u751f\u6162\u6027 HEV \u611f\u67d3\u3002<\/p>\n
\u76ee\u524d\uff0c\u6b27\u6d32\u809d\u810f\u7814\u7a76\u5b66\u4f1a\u7684\u300aHEV \u611f\u67d3\u7684\u4e34\u5e8a\u5b9e\u8df5\u6307\u5357\u300b\u5efa\u8bae\uff0c\u5bf9\u8f93\u8840\u540e\u809d\u9176\u6c34\u5e73\u5f02\u5e38\u7684\u60a3\u8005\u8fdb\u884c HEV \u68c0\u6d4b [2]\u3002\u540c\u65f6\uff0c\u662f\u5426\u5728\u732e\u8840\u8005\u4e2d\u91c7\u7528 NAT \u65b9\u6cd5\u8fdb\u884c HEV \u5e38\u89c4\u7b5b\u67e5\uff0c\u5e94\u7ed3\u5408\u5f53\u5730 TT-HEV \u98ce\u9669\u8fdb\u884c\u8bc4\u4f30\uff0c\u5e76\u5728\u5b9e\u65bd\u4efb\u4f55\u653f\u7b56\u8c03\u6574\u524d\u8fdb\u884c\u6210\u672c-\u6548\u76ca\u5206\u6790 [2]\u3002<\/p>\n
\u5148\u524d\uff0c\u4e00\u9879\u6765\u81ea\u82f1\u683c\u5170\u5357\u90e8\u7684\u7814\u7a76 [3] \u5bf9 225,000 \u540d\u732e\u8840\u8005\u8fdb\u884c\u4e86 HEV RNA \u7b5b\u67e5\u3002\u5171\u68c0\u51fa\u4e03\u5341\u4e5d\u540d\u611f\u67d3 HEV \u57fa\u56e0 3 \u578b\u7684\u732e\u8840\u8005\uff0c\u60a3\u75c5\u7387\u4e3a 1\/2848 (0.04%)\u3002\u5728\u786e\u8bca\u611f\u67d3\u4e4b\u524d\uff0c\u8fd9\u4e9b\u611f\u67d3\u732e\u8840\u8005\u6240\u6350\u732e\u7684 62 \u4efd\u8840\u6db2\u5236\u54c1\u5df2\u8f93\u6ce8\u7ed9 60 \u540d\u60a3\u8005\u3002\u5728 43 \u540d\u968f\u8bbf\u60a3\u8005\u4e2d\uff0c18 \u540d (42%) \u75c5\u4f8b\u53d1\u751f\u611f\u67d3\u3002\u8f6c\u6c28\u9176\u5347\u9ad8\u5728 TT-HEV \u611f\u67d3\u60a3\u8005\u4e2d\u8f83\u4e3a\u5e38\u89c1\u3002\u4e3a\u6210\u529f\u6e05\u9664 TT-HEV \u611f\u67d3\uff0c\u5176\u4e2d 2 \u540d\u60a3\u8005\u9700\u63a5\u53d7\u5229\u5df4\u97e6\u6797\u6cbb\u7597\uff0c1 \u540d\u60a3\u8005\u9700\u51cf\u91cf\u514d\u75ab\u6291\u5236\u6cbb\u7597\u3002\u6b64\u5916\uff0c10 \u540d\u60a3\u8005\u611f\u67d3\u65f6\u95f4\u5ef6\u957f\u3002<\/p>\n
\u5728\u65e5\u672c\u5317\u6d77\u9053\uff0c\u5728 17 \u5e74\u5185\u6709 20 \u540d TT-HEV\u611f\u67d3\u60a3\u8005 [4]\u3002\u5927\u591a\u6570\u611f\u67d3\u5f52\u56e0\u4e8e HEV \u57fa\u56e0 3 \u578b\uff0c\u5176\u4e2d 2 \u540d\u60a3\u8005\u611f\u67d3\u4e3a HEV \u57fa\u56e0 4 \u578b\u3002\u5728\u5177\u6709\u53ef\u7528\u6570\u636e\u7684 19 \u540d\u60a3\u8005\u4e2d\uff0c9 \u540d\u60a3\u6709\u8840\u6db2\u7cfb\u7edf\u6076\u6027\u80bf\u7624\u3002\u672c\u7814\u7a76\u4e2d TT-HEV \u611f\u67d3\u7684 HEV \u6700\u5c0f\u611f\u67d3\u5242\u91cf\u4e3a 3.6\u00d7104 IU HEV RNA\u3002\u636e\u4f30\u8ba1\uff0c\u7528\u4e8e\u8f93\u8840\u7684 HEV \u6c61\u67d3\u8840\u6db2\u5236\u54c1\u7684\u4f20\u67d3\u6027\u4e3a 50%\u3002<\/p>\n
\u53e6\u4e00\u9879\u7814\u7a76\u8868\u660e\uff0c2005 \u5e74\u81f3 2019 \u5e74\uff0c\u91c7\u7528 20 \u4efd\u6df7\u6837 NAT \u68c0\u6d4b\u7684\u732e\u8840\u8005\u4e2d HEV \u611f\u67d3\u7684\u68c0\u51fa\u7387\u4e3a 0.011%\uff082,638,685 \u540d\u732e\u8840\u8005\u4e2d\u6709 289 \u540d\uff09[5]\u3002\u7136\u800c\uff0c\u5f53\u91c7\u7528\u5355\u6837\u672c NAT \u68c0\u6d4b\u65f6\uff0c\u68c0\u51fa\u7387\u5347\u9ad8\u81f3 0.043%\uff081,379,750 \u540d\u732e\u8840\u8005\u4e2d\u6709 597 \u540d\uff09\u3002\u5728\u53d7\u611f\u67d3\u7684\u732e\u8840\u8005\u4e2d\uff0c89%\u8868\u73b0\u51fa HEV \u57fa\u56e0 3 \u578b\uff0c\u800c\u5176\u4f59\u732e\u8840\u8005\u8868\u73b0\u51fa HEV \u57fa\u56e0 4 \u578b\u3002\u81ea\u4ece\u5bf9\u732e\u8840\u8005\u5b9e\u65bd HEV \u7b5b\u67e5\u4ee5\u6765\uff0c\u672a\u518d\u62a5\u544a TT-HEV \u611f\u67d3\u75c5\u4f8b\uff08\u6570\u636e\u622a\u81f3 2019 \u5e74\uff09\u3002<\/p>\n
\u5728\u6cf0\u56fd\uff0c\u56fd\u5bb6\u8840\u6db2\u4e2d\u5fc3\u548c\u533a\u57df\u8840\u6db2\u4e2d\u5fc3\u901a\u8fc7\u68c0\u6d4b HEV RNA \u786e\u5b9a\u732e\u8840\u8005\u4e2d HEV \u611f\u67d3\u7684\u6d41\u884c\u7387\uff0c\u5982\u8868 1 \u6240\u793a [6]\u3002<\/p>\n
\u6839\u636e\u8fd9\u4e9b\u6570\u636e\uff0c\u6cf0\u56fd\u732e\u8840\u8005\u4e2d\u620a\u578b\u809d\u708e\u75c5\u6bd2\u7684\u6d41\u884c\u7387\u76f8\u5bf9\u8f83\u9ad8\uff0c\u533a\u57df\u8840\u6db2\u670d\u52a1\u90e8\u95e8\u5185\u5c24\u4e3a\u660e\u663e\u3002\u56e0\u6b64\uff0c\u6cf0\u56fd\u7ea2\u5341\u5b57\u4f1a\u56fd\u5bb6\u8840\u6db2\u4e2d\u5fc3\u5728 2023\u20132027 \u8d22\u5e74\u671f\u95f4\uff0c\u6bcf\u6708\u5bf9\u7ea6 500 \u4e2a\u8840\u6db2\u5355\u4f4d\u5f00\u5c55\u620a\u578b\u809d\u708e\u75c5\u6bd2\u7b5b\u67e5\u3002<\/p>\n
\n
\u53c2\u8003\u6587\u732e\uff1a<\/em> <\/p>\n [1] <\/a>https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-e.Hepatitis E 20 July 2023. \u4f5c\u4e3a\u4e3a\u60a3\u8005\u63d0\u4f9b\u66f4\u5b89\u5168\u8840\u6db2\u4f9b\u5e94\u7684\u6301\u7eed\u52aa\u529b\u7684\u4e00\u90e8\u5206\uff0c\u4e16\u754c\u5404\u5730\u8d8a\u6765\u8d8a\u591a\u7684\u8840\u5e93\u5f00\u59cb\u5b9e\u65bd\u620a\u578b\u809d\u708e\u75c5\u6bd2 (HEV) \u7b5b\u67e5\u7cfb\u7edf\u3002HEV \u611f\u67d3\u662f\u4e00\u79cd\u5e38\u89c1\u611f\u67d3\uff0c\u53ef\u5728\u90e8\u5206\u60a3\u8005\u4e2d\u5bfc\u81f4\u4e25\u91cd\u751a\u81f3\u5371\u53ca\u751f\u547d\u7684\u540e\u679c\u3002 \u5728\u6cf0\u56fd\uff0c\u6cf0\u56fd\u7ea2\u5341\u5b57\u4f1a\u56fd\u5bb6\u8840\u6db2\u4e2d\u5fc3\u5728 2023\u20132027 \u8d22\u5e74\u671f\u95f4\uff0c\u6bcf\u6708\u5bf9\u7ea6 500 \u4e2a\u8840\u6db2\u5355\u4f4d\u5f00\u5c55 HEV \u7b5b\u67e5\u3002 \u8be5\u5021\u8bae\u65e8\u5728\u964d\u4f4e HEV \u611f\u67d3\u98ce\u9669\uff0c\u5c24\u5176\u662f\u598a\u5a20\u671f\u60a3\u8005\u3001\u514d\u75ab\u529f\u80fd\u53d7\u635f\u60a3\u8005\u4ee5\u53ca\u5176\u4ed6\u9762\u4e34 HEV \u611f\u67d3\u76f8\u5173\u4e0d\u826f\u7ed3\u5c40\u9ad8\u98ce\u9669\u7684\u60a3\u8005\u7fa4\u4f53\u3002 \u5728\u672c\u62a5\u544a\u4e2d\uff0c\u6211\u4eec\u5c06\u56de\u987e HEV \u7684\u6982\u51b5\u53ca\u6d41\u884c\u75c5\u5b66\u7279\u5f81\uff0c\u4ee5\u8bf4\u660e\u4e3a\u4ec0\u4e48\u4e00\u4e9b\u8840\u5e93\u9009\u62e9\u5e94\u5bf9\u8fd9\u4e00\u95ee\u9898\uff1b\u540c\u65f6\u4ecb\u7ecd HEV \u7b5b\u67e5\u6d41\u7a0b\u7684\u5177\u4f53\u5f00\u5c55\u65b9\u5f0f\uff0c\u5305\u62ec\u5728\u5b9e\u9a8c\u5ba4\u6280\u672f\u548c\u653f\u7b56\u5c42\u9762\u7684\u76f8\u5173\u8003\u91cf\u3002\u6700\u540e\uff0c\u6211\u4eec\u5c06\u5c55\u793a\u4e00\u4e9b\u6765\u81ea\u6cf0\u56fd\u7684\u6570\u636e\uff0c\u4ee5\u8bf4\u660e\u6cf0\u56fd\u7ea2\u5341\u5b57\u4f1a\u4e3a\u4f55\u51b3\u5b9a\u5b9e\u65bd HEV \u7b5b\u67e5\u3002 HEV \u6982\u8ff0\u548c\u6d41\u884c\u75c5\u5b66 HEV \u662f\u4e00\u79cd\u6b63\u94fe\u3001\u5355\u80a1\u3001\u65e0\u5305\u819c\u7684 RNA \u75c5\u6bd2\uff0c\u96b6\u5c5e\u4e8e\u809d\u75c5\u6bd2\u79d1\u809d\u75c5\u6bd2\u5c5e\u8be5\u75c5\u6bd2\u81f3\u5c11\u6709\u56db\u79cd\u4e0d\u540c\u7684\u57fa\u56e0\u578b\uff1a\u57fa\u56e0 1 \u578b\u30012 \u578b\u30013 \u578b\u548c 4 \u578b\u3002\u57fa\u56e0 1 \u578b\u548c 2 \u578b\u611f\u67d3\u4eba\u7c7b\uff0c\u800c\u57fa\u56e0 3 \u578b\u548c 4 \u578b\u6d41\u884c\u4e8e\u591a\u79cd\u52a8\u7269\u5bbf\u4e3b\u4e2d\uff0c\u5305\u62ec\u732a\u3001\u91ce\u732a\u548c\u9e7f\u3002\u57fa\u56e0 3 \u578b\u548c 4 \u578b\u5076\u5c14\u4f1a\u611f\u67d3\u4eba\u7c7b [1]\u3002 \u6839\u636e\u4e16\u754c\u536b\u751f\u7ec4\u7ec7 (WHO) \u7684\u6570\u636e\uff0c\u5168\u7403\u6bcf\u5e74\u65b0\u8bca\u65ad\u51fa\u7ea6 2000 \u4e07\u4f8b\u620a\u578b\u809d\u708e\u75c5\u6bd2\u611f\u67d3\uff0c\u5176\u4e2d\u7ea6\u6709 330 \u4e07\u4f8b\u4e3a\u6709\u75c7\u72b6\u611f\u67d3\u75c5\u4f8b […]<\/p>\n","protected":false},"author":1,"featured_media":138804,"parent":0,"menu_order":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"tags":[12041,12356,12364,14294],"pillarandcategory":[8101,282,286,324,309],"reporter":[14314],"class_list":["post-145632","acf_article","type-acf_article","status-publish","has-post-thumbnail","hentry","tag-thailand","tag-12356","tag-12364","tag-14294","pillarandcategory-blood-screening-2","pillarandcategory-disease-area","pillarandcategory-infectious-diseases","pillarandcategory-molecular-diagnostics","pillarandcategory-operations","reporter-phandee-watanaboonyongcharoen"],"acf":[],"_links":{"self":[{"href":"https:\/\/labinsights.com\/zhcn\/wp-json\/wp\/v2\/acf_article\/145632","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/labinsights.com\/zhcn\/wp-json\/wp\/v2\/acf_article"}],"about":[{"href":"https:\/\/labinsights.com\/zhcn\/wp-json\/wp\/v2\/types\/acf_article"}],"author":[{"embeddable":true,"href":"https:\/\/labinsights.com\/zhcn\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":3,"href":"https:\/\/labinsights.com\/zhcn\/wp-json\/wp\/v2\/acf_article\/145632\/revisions"}],"predecessor-version":[{"id":148225,"href":"https:\/\/labinsights.com\/zhcn\/wp-json\/wp\/v2\/acf_article\/145632\/revisions\/148225"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/labinsights.com\/zhcn\/wp-json\/wp\/v2\/media\/138804"}],"wp:attachment":[{"href":"https:\/\/labinsights.com\/zhcn\/wp-json\/wp\/v2\/media?parent=145632"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/labinsights.com\/zhcn\/wp-json\/wp\/v2\/tags?post=145632"},{"taxonomy":"pillarandcategory","embeddable":true,"href":"https:\/\/labinsights.com\/zhcn\/wp-json\/wp\/v2\/pillarandcategory?post=145632"},{"taxonomy":"reporter","embeddable":true,"href":"https:\/\/labinsights.com\/zhcn\/wp-json\/wp\/v2\/reporter?post=145632"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n[2]<\/a> EASL Clinical Practice Guidelines on hepatitis E virus infection.Journal of hepatology. 2018;68(6):1256-71.
\n[3]<\/a> Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England.Lancet (London, England). 2014;384(9956):1766-73.
\n[4]<\/a> Satake M, Matsubayashi K, Hoshi Y, Taira R, Furui Y, Kokudo N, et al. Unique clinical courses of transfusion-transmitted hepatitis E in patients with immunosuppression.Transfusion. 2017;57(2):280-8.
\n[5]<\/a> Sakata H, Matsubayashi K, Iida J, Nakauchi K, Kishimoto S, Sato S, et al. Trends in hepatitis E virus infection: Analyses of the long-term screening of blood donors in Hokkaido, Japan, 2005-2019. Transfusion. 2021;61(12):3390-401.
\n[6] Pitchanan Khamsawang, Wilawan Sakram, Peeraya Suriya, Duangnapa Intarasongkrau, Patcharida Wongkittikul, Chompunekh Tungpunya, et al. Screening for Hepatitis E Virus Infection in Blood Donors. 2023.<\/p>\n","protected":false},"excerpt":{"rendered":"